Background: Detection and treatment of blister-like intracranial aneurysms as a source of subarachnoid hemorrhage (SAH) can be challenging. In the past the results of both microsurgical and endovascular treatment were difficult. We present our experience with the treatment of blister-like aneurysms in the acute phase of SAH using microsurgical clipping, endovascular parent vessel occlusion or flow diversion. Methods: A retrospective analysis of the cases of eight consecutive patients presenting in the acute phase after SAH from an intracranial blister aneurysm was performed. The demographic data of the patients, aneurysm characteristics, the clinical results of the treatment and the follow-up examinations were recorded. Procedural safety margins and aneurysm occlusion on follow-up digital subtraction angiography were the main interest of this evaluation. Results: Between January 2012 and November 2017 a total of eight ruptured blister aneurysms were treated in our center, six patients endovascularly. Five patients were treated in the acute phase of SAH, four by flow diversion. All endovascular procedures were feasible and no procedure-related complications were observed, especially no recurrent hemorrhage. In the first angiographic follow-up all blood blister-like aneurysms were completely occluded; two of the six patients treated by flow diverter implantation showed mild, transient intimal hyperplasia without clinical symptoms or the need for treatment. Conclusions: Endovascular flow diversion is a viable option in the acute phase after SAH due to the rupture of a blister aneurysm. Implants with reduced thrombogenicity, obviating dual-platelet function inhibition, and flow diverters for vessel bifurcations would extend the indications for this treatment modality.
Introduction
Blister aneurysms, or blood blister-like aneurysms (BBAs), are usually located around the supraclinoid internal carotid artery (ICA). They are defined as small aneurysms at nonbranching sites on the dorsal wall of this arterial segment with high tendency for rupture. BBAs are a rare cause of subarachnoid hemorrhage (SAH); however, they are important to recognize because of significant clinical implications. The treatment of these lesions is complicated and various treatment approaches, both endovascular and microsurgical, have been proposed. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Despite significant progress in endovascular and microsurgical treatment, no reliable management strategy has been established so far.
With the recent availability of various flow diverters (FDs) for neurointerventional procedures, FD implantation has become an additional therapeutic option for these lesions. To date few reports have been published on the treatment of BBAs with FDs in the acute phase of SAH. [13] [14] [15] However, clinical experience and longterm follow-up data are still scarce and treatment strategies are a matter of controversy.
In this study we review the treatment strategies as well as the clinical and angiographic outcome of eight consecutive patients with acute SAH due to ruptured anterior circulation BBAs, treated in one center by either endovascular or microsurgical means.
We intend to elucidate the advantages and disadvantages of each approach.
Methods and materials Patient population
In retrospect we identified from our institutional database all patients with an acute SAH due to a BBA in the anterior circulation. Patients were treated in a single center between January 2012 and November 2017. BBAs were defined as aneurysms with a diameter 2 mm. Eight patients met these inclusion criteria. We analyzed the demographic data, clinical presentation, aneurysm location, treatment modality, clinical outcome and angiographic follow-up results.
Treatment modality
All patients had diagnostic angiographies. Based on these images the decision for endovascular therapy (EVT) or microsurgical clipping was made between an experienced interventional neuroradiologist and a vascular neurosurgeon.
General circumstances
All treatments were performed under general anesthesia. Informed consent was obtained from the patients or their legal representatives prior to treatment.
Microsurgical clipping
For both operations a pterional approach and an operation microscope was used, with the aim of direct clipping of the BBA.
EVT
All patients treated in the acute phase of SAH received dual-platelet function inhibition medication comprising 1 Â 500 mg acetyl salicylic acid (ASA) (aspirin i.v., Bayer Vital) intravenous (IV) and 180 mg ticagrelor (Brilique, AstraZeneca) per os (PO) at least two hours prior to the procedure. The effectiveness of this medication was monitored by using the Multiplate Analyzer (Roche Diagnostics) and/or the VerifyNow test (Accriva), in recent patients with both tests. In patients with an inadequate platelet inhibition by ticagrelor, 1 Â 60 mg prasugrel (Efient, Daiichi Sankyo) PO was used as a substitute.
The post-procedural antiplatelet medication regimen with 1 Â 100 mg ASA PO daily and 2 Â 90 mg ticagrelor or 1 Â 10 mg prasugrel PO daily was continued for 12 months, then ticagrelor or prasugrel was stopped and ASA was continued for life.
One patient who was treated 13 months after an acute SAH because of a failed microsurgical attempt received a loading dose with 1 Â 500 mg ASA and 1 Â 300 mg clopidogrel PO three days prior to the treatment. Owing to clopidogrel resistance, the regimen was changed to 1 Â 180 mg ticagrelor PO given on the day of the treatment.
All procedures were performed via the right common femoral artery with a 6Fr or 8Fr guide catheter. Biplane digital subtraction angiography (DSA) systems (Siemens, Erlangen, Germany) with calibrated built-in measuring tools were used. The p64 FD (phenox, Bochum, Germany) was selected as the implant with the best combination of dense coverage and high flexibility. All FDs were implanted via an Excelsior XT27 (Stryker) microcatheter. The FD sizing was decided so that the shortest possible device with a physical diameter as close as possible to the measured diameter of the target vessel was chosen. Every effort was made to avoid both under-or oversizing.
Procedural assessment and follow-up examination
Patients were clinically examined by board-certified neurosurgeons or neurologists not directly involved in the procedures prior to the operation or EVT and during follow-up visits. The results of these examinations were graded according to the Hunt and Hess classification and the modified Rankin Scale score (mRS).
The endovascular procedures were reviewed and classified as (1) ''no complication,'' (2) ''failed attempt,'' (3) ''hemorrhagic complication,'' (4) ''ischemic complication'' or (5) ''hemorrhagic and ischemic complication.' ' The clinical sequelae of any complication were classified as (1) ''clinically irrelevant,'' (2) ''transient neurological deficit,'' (3) ''permanent minor neurological deficit'' (i.e. mRS 1 or 2), (4) ''permanent major neurological deficit'' (i.e. mRS 3-5) or (5) ''death.' ' After the procedure and/or prior to discharge all patients underwent either computed tomography (CT) or magnetic resonance imaging examinations to assess possible procedure-related complications. The results of these examinations became part of the assessment of the procedures.
Angiographic follow-up was scheduled routinely at three, nine and 24 months after EVT. Standard radiographic projections as well as the respective working projections were used to assess the patency of the parent vessel and the occlusion of the BBA. In case of doubt rotational angiographies with three-dimensional reconstruction were performed in addition. The occlusion of the BBA was graded as (1) ''complete,'' (2) ''neck remnant'' or (3) ''aneurysm perfusion.''
The lumen loss in the case of in-stent stenosis was graded as (1) < 50%, (2) 50%-75%, and (3) > 75%.
Results

Population
We identified eight patients (four female) with a median age of 52.5 years (range . The majority of BBAs were located on the para-or supraclinoid ICA (n ¼ 4). Five patients presented with only mild clinical symptoms (Hunt and Hess grade I-II). However, three patients had suffered a severe SAH (Hunt and Hess grade III-IV). The results are summarized in Table 1 .
Of the eight patients, computed tomography angiography (CTA) revealed an aneurysm in three cases; in five cases the BBA was not detected in the CTA.
Those aneurysms detected in the CTA could be verified in the DSA. Overall DSA detected all BAAs; however, in two cases (Patient No. 3 and 8) the BBA was missed in the first two DSAs. This might be due to the uncommon location of these BBAs: namely BAAs of the middle cerebral artery (MCA) in the M3 segment and the anterior communicating artery (AcomA).
Treatment modality and feasibility
Out of the eight patients with SAH due to a BBA, five patients underwent EVT in the acute phase of the SAH. Of these patients, three were treated by implantation of a single FD; one patient was treated by implantation of two FDs. One patient was treated by endovascular parent vessel occlusion (PVO) because of the distal location of the BBA on an M3 branch of the MCA. In all procedures the attempted implantation of the FD was feasible. No unexpected procedure-related complications were encountered. The patient who underwent endovascular PVO suffered ischemic complications as anticipated due to the treatment-induced parenchymal ischemia. There were no cases of recurrent hemorrhage following EVT or due to the antiplatelet medication. The median interval between SAH and EVT was seven days (range 1-19 days). The results are summarized in Tables 2 and 3 . Three patients underwent microsurgery. In one patient the decision for microsurgical treatment was made based on the peripheral location of the aneurysm at the A2 segment and the small diameter of the parent artery. Clipping of the aneurysm failed at the first attempt because of vasospasm. At the second attempt, performed 10 days later, the aneurysm was successfully clipped. The second patient had an aneurysm of the MCA, which was believed to be the cause of the SAH. This aneurysm was not suitable for coil occlusion and the patient underwent surgery. During the operation the formerly not recognized BBA of the supraclinoid ICA reruptured. This aneurysm was eventually treated by surgical wrapping. However, a follow-up DSA after 13 months demonstrated a persistence of the aneurysm. Therefore, EVT was successfully performed by using a single FD. The third patient had a blister aneurysm of the right MCA bifurcation that was also not suitable for EVT and therefore the decision for microsurgical therapy was made. The aneurysm ruptured during the operation but was nevertheless clipped successfully; however, a DSA four days after the surgery revealed a dissection of the M1 segment with a transient vessel occlusion (see illustrative case). The microsurgical treatments were performed one, two and eight days after the SAH, respectively. The results are summarized in Tables 2 and 3 .
Angiographic and clinical follow-up
Angiographic follow-up was available for seven patients. The patients treated with FD implantation had an initial angiographic follow-up after a median of three months after EVT (range 3-4 months). Hereby complete occlusion of the BBA was confirmed in all patients.
The patients who underwent clipping of the BBA had an angiographic follow-up on the day after each surgery. The patient with wrapping of the BBA had further angiographic follow-ups after seven days and 12 months.
None of the aneurysms reruptured after treatment. Seven out of eight patients had a good clinical outcome at discharge (mRS 2). The patient who was treated by PVO had a poor clinical outcome at discharge (mRS 4). No patient died. The results are summarized in Tables 2 and 3 .
Illustrative case 1
A 23-year-old male patient presented with severe headache, loss of vision and two episodes of loss of consciousness. A CT scan of the head revealed a mild SAH in the right Sylvian fissure (Hunt and Hess I; Figure 1(a) ). A contrast-enhanced CTA did not show an aneurysm. Under general anesthesia the patient underwent DSA, which showed a BBA of the right MCA bifurcation (Figure 1(b) and (c)). As the BBA was not suitable for EVT because of the location and the small size, the decision for microsurgical therapy was made. The patient was transferred to the operating room immediately. The intraoperative situs of the right MCA bifurcation showed a blood clot within the bifurcation and the tiny BBA was not readily visible (Figure 2(a) ). During meticulous preparation of the MCA bifurcation the BBA reruptured. Further dissection showed that the rupture had destroyed the wall of the MCA bifurcation completely so the wall was reconstructed with a curved Sugita clip without temporary clipping of the afferent artery (Figure 2(b) ). Four days after surgery the patient presented with a mild paresis of his left arm. The patient underwent a DSA examination, as the most likely reason for this neurological symptom was vasospasm. The angiography revealed then a dissection of the right M1 segment. As the patient's symptoms regressed completely after elevation of the blood pressure to 150 mmHg, it was decided to treat the patient conservatively with 100 mg aspirin PO daily and low molecular-weight heparin. With this treatment regimen the patient did well and did not show new neurological symptoms. A follow-up DSA after three more days showed a complete occlusion of the right M1 segment with good leptomeningeal collaterals from the right anterior cerebral artery (ACA) (Figure 3(b) ). The treatment regimen was continued. Another follow-up DSA after another 16 days showed a partial recanalization of the M1 segment and resolution of the thrombus (Figure 3(c) ). The patient was discharged two days later with 100 mg aspirin PO daily as medication and without any neurological symptoms.
Illustrative case 2
A 46-year-old male patient presented with severe headache lasting a few days. A native CT scan revealed a circumscript SAH in the anterior basal cistern around the clinoid segment of the left ICA (Figure 4 (a) and (b)). A CTA showed a small aneurysm of the left paraclinoid ICA (Figure 4(c) ). The BBA was confirmed by a DSA performed on the day of admission (Figure 5(a) and (b) ). Furthermore, vasospasm of the left ACA was already observed. The decision for EVT was made between an interventional neuroradiologist and a neurosurgeon concordantly. After obtaining informed consent from the patient the treatment was scheduled seven days after admission. On the day of EVT the patient received dual-antiplatelet medication with a loading dose of 500 mg aspirin and 180 mg ticagrelor. Adequate platelet inhibition was achieved hereby. The implantation of the FD in the left ICA was feasible without any complications (Figure 6(a)-(c) ). The patient was kept on 100 mg aspirin PO daily and 2 Â 90 mg ticagrelor PO daily to maintain platelet inhibition. The patient was discharged home 12 days after EVT showing a complete recovery. The angiographic follow-up after three months confirmed the complete occlusion of the aneurysm and patency of the parent vessel (Figure 7(a) and (b) ).
Discussion
BBAs are small, typically < 2 mm diameter, sidewall lesions arising from nonbranching sites of an intradural artery. A dissecting etiology is thought to be the underlying mechanism of their development. 16 They are predominantly found on the ICA 17, 18 and are characterized by their small size, broad-based aneurysm neck and high fragility with a tendency to rerupture or growth to saccular aneurysms within a few days. 11, 17, 19 Because of these characteristics, treatment of these lesions is challenging and risky.
Several EVT, microsurgical and hybrid treatment approaches have been published although there is still no consensus on the optimal treatment strategy. [1] [2] [3] [4] [5] 7, 11, [20] [21] [22] [23] Endovascular options can be categorized as either deconstructive (e.g. PVO) or reconstructive (e.g. coil occlusion, stent-assisted coiling, flow diversion, covered stent implantation) or a combination thereof.
PVO is feasible only in patients with adequate collateral supply, and in the absence of adequate collaterals this option carries a significant risk of ischemic complications. Park et al. 24 treated five patients with ruptured ICA BBAs with endovascular ICA occlusion, mostly in the subacute phase. Balloon test occlusion (BTO) was performed in all patients prior to the occlusion and in all but one case there was a good clinical outcome. In patients with failed BTO additional extracranial-intracranial (EC-IC) bypass surgery can be performed prior to PVO of the ICA. However, loss of the ICA during the first 7-10 days after SAH carries a high probability of poor outcome because of the risk of subsequent vasospasm. Therefore, successful BTO in the early phase may not guarantee a satisfactory clinical outcome and because of this PVO should be used with caution in the acute setting. 25 Coil occlusion is an alternative treatment; however, because of the morphology of the aneurysms straight coiling alone is often not feasible and also dangerous owing to the fragile wall of these lesions. Coiling alone has been found to be associated with high rates of intraoperative rupture, regrowth and recurrent hemorrhage. 24, 25 Linfante et al. successfully treated nine out of 10 patients (eight ICA and two MCA) using the Pipeline embolization device (PED; Medtronic, Dublin, Ireland). 26 In our series four of eight patients were treated with FDs only in the acute phase. One more patient was treated after a failed surgical attempt approximately one year after the SAH. In all cases the BBA was occluded on the delayed angiography with no evidence of aneurysm recurrence or regrowth and complete patency of the parent vessels in the long-term follow-up. Most important, there were no cases of recurrent hemorrhage despite the prolonged use of dual-antiplatelet agents. Recent reports have focused on FDs to treat BBAs in the acute phase of SAH, confirming an angiographic and clinical outcome superior to microsurgical therapy. 13, 14, 26, 27 One of the major drawbacks of FDs, as any stentassisted technique, is the need for antiaggregation. Dual-antiplatelet medication in the setting of acute SAH is controversial as aneurysm rerupture, although relatively uncommon, may occur. 29, 30 Additionally any surgical procedure after FD insertion carries an increased risk of hemorrhagic issues due to the dualantiplatelet medication. This is true for external ventricular drainage (EVD) placement, decompressive craniectomy or even tracheostomy. 7 If the potential need for any minor or major surgical intervention is anticipated, this should be carried out prior to the initiation of the dual-platelet function inhibition. Therefore we always place an EVD, if needed, prior to the FD implantation. None of our patients suffered a hemorrhage related to these procedures. The introduction of surface-modified FD, with the need for only a single antiplatelet medication, may prove particularly useful in the acute situation. We are aware of a single publication documenting the use of these new devices in an acutely ruptured fusiform aneurysm, 31 and to our knowledge there have been no reports on the use of these devices to treat acutely ruptured BBAs. In this case 325 mg of ASA was given two hours prior to the procedure and prior to commencement of ASA an EVD was inserted. The fusiform aneurysm of the V4 segment of the right vertebral artery was treated using a combination of coils and two Pipeline Shield FDs (Medtronic). Although there were no intraoperative complications the stent construct was thrombosed at 10-day follow-up angiography, and antiplatelet testing performed at this time revealed an inadequate response to the maintenance dose of aspirin (81 mg). Therefore, while these devices may prove useful in the future, more clinical experience is required.
A second drawback is that the aneurysm is not occluded immediately with the consequent risk of rebleeding as has been previously reported. 30 However, when comparing the number of patients with BBAs treated with FDs in the acute phase of SAH with the number of reports about rebleedings in the same patients, this seems to be a rare exception and might be related to a specific aneurysm characteristic such as a circumferential type of BBA, similar to a dissection which have been reported to be more prone to rebleeding. 32 The various microsurgical treatment options such as trapping, clipping and wrapping have also been reported to be associated with an increased procedural risk due to the features of BBAs and the location on the dorsal vessel wall, which makes the surgical access even more difficult. 21, 22, 33 Surgical trapping carries similar risks to endovascular PVO and requires adequate collaterals or EC-IC bypass if these are not present. Direct clipping of these aneurysms carries a significant risk of intraoperative rupture, as occurred in one of our cases, and this risk may be as high as 50%. 25, 34, 35 The principal risk comes from the dissection of the BBA. Clipreinforced wrapping is an alternative but suboptimal wrapping of the diseased segment is a possibility due to the difficulty in identifying the precise borders of the aneurysm as well as perforator branches in the local vicinity that may obstruct complete wrapping of the aneurysm. This may then lead to subsequent rebleeding or regrowth and failure to occlude the aneurysm as was seen in one of our cases that then went on to EVT. Several studies have reported that the outcome of patients with BBAs after EVT is more favorable compared to microsurgery. 20, 21 Shah et al. performed a systematic review of safety, efficacy and outcome of EVT and microsurgical treatment options for BBAs. They identified 256 published patients who were treated for BBAs. They showed that EVT seems to have a better clinical outcome despite the disadvantage of a delayed aneurysm occlusion. 23 The limitations of this study are the retrospective nature and the small number of enrolled patients. Both are difficult to overcome, given the low incidence of BBAs, which has been reported as low as 1%. 36 All FD procedures in this series have been carried out with a single device type (p64) in a high-volume neurovascular center with >1200 endovascular interventions, including > 250 aneurysms, annually. Results may vary depending on the devices used and the skills and experience of the operators involved.
Conclusions
The treatment of BBAs in the acute phase of SAH with FD implantation is feasible and effective and yields good clinical and angiographic outcome. FD is a promising approach and is, in our practice, considered the therapy of choice. The management of these patients would be tremendously facilitated, however, if FDs were available without the necessity for dual-antiplatelet therapy.
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